Statistics from Altmetric.com
Antibodies to the myelin oligodendrocyte glycoprotein are associated with a relapsing disease course, with optic neuritis being the most frequent clinical presentation at onset and relapse
Antibodies to the myelin oligodendrocyte glycoprotein (MOG) are present in patients with acute disseminated encephalomyelitis (ADEM), aquaporin-4 antibody-negative neuromyelitis optica spectrum disorders (NMOSD), isolated optic neuritis (ON), transverse myelitis, encephalomyelitis or brainstem encephalitis, but only rarely in people with multiple sclerosis (MS). Initial studies indicated that MOG antibodies are associated with a monophasic and more benign disease course, whereas recent findings challenged this assumption. These studies revealed that MOG antibodies are also found in patients with a recurrent non-MS disease course, particularly in adolescents and adults.1–4 The most frequent clinical presentation at relapse is ON, and the majority of …
Contributors The author wrote the commentary solely.
Competing interests The Neurological Research Laboratory (Medical University of Innsbruck and Tirol Kliniken, Innsbruck, Austria) receives payments for antibody assays (AQP4 and antineuronal antibodies) and for MOG and AQP4 antibody validation experiments organised by Euroimmun (Germany).
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.